Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × Methylprednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3 Burkitt Lymphoma 2 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Hematologic Neoplasms 1 Brain Neoplasms 1

Interventions

Radiosurgery 23 Magnetic Resonance Spectroscopy 18 pembrolizumab 10 Temozolomide 10 Specimen Handling 8 Bevacizumab 8 Radiotherapy 5 Nivolumab 5 Magnetic Resonance Imaging 5 Ipilimumab 5 Cyclophosphamide 5 Neuropsychological Tests 4 Carboplatin 4 Capecitabine 4 fludarabine 3 fluciclovine F-18 3 encorafenib 3 abemaciclib 3 Radiation 3 Proton Therapy 3 Mental Status and Dementia Tests 3 Etoposide 3 Dexamethasone 3 Blood Specimen Collection 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 osimertinib 2 niraparib 2 binimetinib 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05789589 2026-03-04

ADORATION

Baptist Health South Florida

Phase 1/2 Recruiting

Brain Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡